| Table 2. Mean ± SD of the malondialdehyde (MDA), Catalase (CAT) and superoxide dismutase (SOD) levels of rats in different groups | |||
| Groups | Parameter | ||
| MDA (nmol/ml-1) | CAT (U/ml-1) | SOD (U/ml-1) | |
| Group A | 3.74±2.1a | 9.45±0.9 | 8.27±0.5a,b,c |
| Group B | 8.52±1.4a,b,c,d | 3.34±0.7a,b | 2.2±2.3a,d |
| Group C | 3.32±0.9b | 5.65±1.2a | 4.68±1.3b,e |
| Group D | 4.05±1.1c | 9.5±1.1 | 7.88±0.6d,e,f |
| Group E | 4.44±0.7d | 5.11±2.2b | 4.56±0.8c,f |
| Same superscript in each column indicate
significant differences at p<0.05. Group (A) which served as the control group and received a daily oral gavage normal saline Group (B) diabetic rats, which received streptozotocin. Group (C) diabetic rats were administered P. atlantica extract (200 mg/kg) daily by gavage. Group (D) non-diabetic rats received similar doses of P. atlantica extract alone. Group (E) diabetic rats were administered glibenclamide (200 mg/kg) daily by gavage. |
|||